A handheld device which can remotely diagnose the presence of cancer cells is on the horizon with biotech company Universal Biosensors (ASX: UBI) partnering with the Peter MacCallum Cancer Centre on the project. Under the agreement, Peter Mac will supply cancer patient samples to Universal Biosensors which will use the plasma samples in their trials
Read More
Besides their names, there are a lot more similarities that could one day be unlocked between tech unicorn CM.com (AMS: CMCOM), which recently surpassed USD $1 billion market cap, and microcap artificial intelligence company Crowd Media (ASX: CM8). Both conversational commerce companies are headquartered in the Netherlands with CM.com having just surpassed the billion dollar
Read More
COVID-19 represents unchartered territory for everyone. Governments and various organisations across the globe have struggled to develop systems, policies and coordinate programs whilst researchers have scrambled to pull together clinically valid trials to deepen our understanding of our latest threat. ResApp (ASX: RAP) is a digital health company developing smartphone apps for both the diagnosis
Read More
Mask-ne, iso skin, whatever the beauty blogs have dubbed it, acne sucks. Yes, one of the many irritating side effects of this pesky pandemic is the resurgence of my teenage skin. Regular mask wearing and heightened stress has contributed to my new spotty appearance. Sadly, my bathroom wouldn’t make for a very good “shelfie” these
Read More
Having looked after ourselves through the pandemic as evidenced by their $16.5 million in sex toy sales over the past year, quasi-explorer Delecta (ASX: DLC) is seeking to multiply that revenue in the form of rising uranium prices. Yes, you did read that right. While dabbling in mineral exploration, Delecta has continued to operare its
Read More
